Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine growth hormone as add-on therapy for thin endometrium in frozen embryo transfer
IRCT20110908007513N18Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in infertility and Endometrial hypotrophy comparing Growth hormone + conventional hormone therapy with Placebo + conventional hormone therapy (2 arms). Started Apr 2024; status: completed.
02
Drugs
somatropin
03
Conditions
infertilityEndometrial hypotrophy
Beyond the preview
Go deeper on IRCT20110908007513N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110908007513N18.